Literature DB >> 24473062

Structural and mechanistic insights into the kynurenine aminotransferase-mediated excretion of kynurenic acid.

Ken Okada1, Clement Angkawidjaja2, Yuichi Koga3, Shigenori Kanaya3.   

Abstract

Kynurenine aminotransferase (KAT) is a homodimeric pyridoxal protein that mediates the catalytic conversion of kynurenine (KYN) to kynurenic acid (KYA), an endogenous N-methyl-d-aspartate (NMDA) receptor antagonist. KAT is involved in the biosynthesis of glutamic and aspartic acid, functions as a neurotransmitter for the NMDA receptor in mammals, and is regulated by allosteric mechanisms. Its importance in various diseases such as schizophrenia makes KAT a highly attractive drug target. Here, we present the crystal structure of the Pyrococcus horikoshii KAT (PhKAT) in complex with pyridoxamine phosphates (PMP), KYN, and KYA. Surprisingly, the PMP was bound to the LYS-269 of phKAT by forming a covalent hydrazine bond. This crystal structure clearly shows that an amino group of KYN was transaminated to PLP, which forms a Schiff's base with the LYS-269 of the KYN. Thus, our structure confirms that the PMPs represent an intermediate state during the KAT reaction. Thus, PhKAT catalyzes the sequential conversion of KYN to KYA via the formation of an intermediate 4-(2-aminophenyl)-2,4-dioxobutanoate (4AD), which is spontaneously converted to KYA in the absence of an amino group acceptor. Furthermore, we identified the two entry and exit sites of the PhKAT homodimer for KYN and KYA, respectively. The structural data on PhKAT presented in this manuscript contributes to further the understanding of transaminase enzyme reaction mechanisms.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Excretion mechanism; Kynurenic acid; Kynurenine aminotransferase; Pyridoxamine phosphate

Mesh:

Substances:

Year:  2014        PMID: 24473062     DOI: 10.1016/j.jsb.2014.01.009

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  3 in total

1.  Vitamin B6 Reduces Neurochemical and Long-Term Cognitive Alterations After Polymicrobial Sepsis: Involvement of the Kynurenine Pathway Modulation.

Authors:  Lucinéia Gainski Danielski; Amanda Della Giustina; Mariana Pereira Goldim; Drielly Florentino; Khiany Mathias; Leandro Garbossa; Rosiane de Bona Schraiber; Ana Olívia Martins Laurentino; Marina Goulart; Monique Michels; Karina Barbosa de Queiroz; Markus Kohlhof; Gislaine Tezza Rezin; Jucélia Jeremias Fortunato; Joao Quevedo; Tatiana Barichello; Felipe Dal-Pizzol; Roney S Coimbra; Fabricia Petronilho
Journal:  Mol Neurobiol       Date:  2017-09-06       Impact factor: 5.590

Review 2.  Relevance of Alternative Routes of Kynurenic Acid Production in the Brain.

Authors:  L A Ramos-Chávez; R Lugo Huitrón; D González Esquivel; B Pineda; C Ríos; D Silva-Adaya; L Sánchez-Chapul; G Roldán-Roldán; V Pérez de la Cruz
Journal:  Oxid Med Cell Longev       Date:  2018-05-24       Impact factor: 6.543

Review 3.  Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword?

Authors:  Aleksandra Ostapiuk; Ewa M Urbanska
Journal:  CNS Neurosci Ther       Date:  2021-12-03       Impact factor: 5.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.